GENNEX LABORATORIES
Back to Balance Sheet
|
GENNEX LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | - | - | ₹0.74 Cr | ₹1.70 Cr | ₹1.60 Cr |
What is the latest Contingent Liabilities ratio of GENNEX LABORATORIES ?
Year | Contingent Liabilities |
---|---|
Mar2024 | - |
Mar2023 | - |
Mar2022 | ₹0.74 Cr |
Mar2021 | ₹1.70 Cr |
Mar2020 | ₹1.60 Cr |
How is Contingent Liabilities of GENNEX LABORATORIES Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | - | 0 | |
Mar2023 | - | -100.00 | |
Mar2022 | ₹0.74 Cr | -56.70 | |
Mar2021 | ₹1.70 Cr | 6.11 | |
Mar2020 | ₹1.60 Cr | - |
Compare Contingent Liabilities of peers of GENNEX LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GENNEX LABORATORIES | ₹271.7 Cr | -6.9% | -6.4% | -54% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,682.0 Cr | -2% | 2% | -16.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹150,985.0 Cr | -5% | -6.6% | 5.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,862.0 Cr | -0.4% | 0.5% | 5.2% | Stock Analytics | |
CIPLA | ₹121,294.0 Cr | -2.4% | -5.4% | -8.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,132.0 Cr | -5.8% | -4.4% | -8.4% | Stock Analytics |
GENNEX LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GENNEX LABORATORIES | -6.9% |
-6.4% |
-54% |
SENSEX | -2.2% |
0.6% |
-5.8% |
You may also like the below Video Courses